Emily Anne Scraggs
Directeur/Bestuurslid bij Talisman Therapeutics Ltd.
Actieve functies van Emily Anne Scraggs
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Talisman Therapeutics Ltd.
 Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | - | - |
| Corporate Officer/Principal | - | - |
Loopbaan van Emily Anne Scraggs
Eerdere bekende functies van Emily Anne Scraggs
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Gen2 Neuroscience Ltd.
 Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Directeur/Bestuurslid | 07-01-2016 | - |
| Oprichter | 07-01-2016 | - |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
Operationeel
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Gen2 Neuroscience Ltd.
Gen2 Neuroscience Ltd. Pharmaceuticals: GenericHealth Technology Gen2 Neuroscience Ltd. develops novel treatments for dementia targeting abnormal forms of the essential cellular protein tau. The company was founded by Frederick John Livesey in January 07, 2016 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Talisman Therapeutics Ltd.
Talisman Therapeutics Ltd. BiotechnologyHealth Technology Talisman Therapeutics Ltd. is a human stem cell research and development company. The firm is committed for revolutionizing the discovery of treatments for Alzheimer’s disease. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Emily Anne Scraggs
- Ervaring
